Healthcare group Fresenius tops Q4 operating profit expectations
Fresenius to assess whether state aid impacts bonus, dividend payouts
Fresenius launches biosimilar version of AbbVie's Humira at 5% discount
Fresenius SE CEO to quit after earnings outlook sours